<?xml version="1.0" encoding="UTF-8"?><CAS version="2"><uima.cas.Sofa _indexed="0" _id="1" sofaNum="1" sofaID="_InitialView" mimeType="text" sofaString="P10704499A0682 Alternatively, PC12-E2 cells were submitted to treatment with antibodies to the fibroblast growth factor (FGF) receptor, inhibitors of the nonreceptor tyrosine kinase p59(fyn), PLC, PKC and MEK and an activator of PKC, phorbol-12-myristate-13-acetate (PMA)."/><uima.tcas.DocumentAnnotation _indexed="1" _id="8" _ref_sofa="1" begin="0" end="272" language="x-unspecified"/><edu.cmu.tanl.type.gene _indexed="1" _id="13" _ref_sofa="1" begin="69" end="90" Gene="fibroblast growth factor"/><edu.cmu.tanl.type.gene _indexed="1" _id="18" _ref_sofa="1" begin="92" end="103" Gene="FGF) receptor"/><edu.cmu.tanl.type.gene _indexed="1" _id="23" _ref_sofa="1" begin="120" end="147" Gene="nonreceptor tyrosine kinase p59"/><edu.cmu.tanl.type.gene _indexed="1" _id="28" _ref_sofa="1" begin="149" end="151" Gene="fyn"/><edu.cmu.tanl.type.gene _indexed="1" _id="33" _ref_sofa="1" begin="154" end="156" Gene="PLC"/><edu.cmu.tanl.type.gene _indexed="1" _id="38" _ref_sofa="1" begin="158" end="160" Gene="PKC"/><edu.cmu.tanl.type.gene _indexed="1" _id="43" _ref_sofa="1" begin="164" end="166" Gene="MEK"/><edu.cmu.tanl.type.gene _indexed="1" _id="48" _ref_sofa="1" begin="170" end="180" Gene="an activator"/><edu.cmu.tanl.type.gene _indexed="1" _id="53" _ref_sofa="1" begin="183" end="185" Gene="PKC"/></CAS>